Valsartan

CAS 137862-53-4 35 current records 5 historicalSmall Molecule

Who holds supplier records for Valsartan? 35 organisations hold a current record for Valsartan: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 27 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (23), China (7), Netherlands (2), United States (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Valsartan: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/valsartan

Reading the evidence

  • 35 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    23 of the 34 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 21 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (35)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Valsartan. Country is the organisation's recorded country, not necessarily the manufacturing site.

India23China7Netherlands2United States1Slovenia1Country not recorded for 1
Need Valsartan sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (27)

Certificates of Suitability on the EDQM register for Valsartan, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 50 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
CEP 2018-116 - Rev 02
Valsartan
Oct 2026—
JUBILANT BIOSYS LIMITED MysuruIN
CEP 2011-110 - Rev 11
Valsartan
Sept 2026—
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2024-113 - Rev 04
Valsartan, Process III
Jun 2026—
Changzhou Pharmaceutical Factory ChangzhouCN
CEP 2025-430 - Rev 00
Valsartan
May 2026Inspected Apr 2025
Italy
ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. ZhuhaiCN
CEP 2019-106 - Rev 03
Valsartan
Apr 2026—
HETERO LABS LIMITED HyderabadIN
CEP 2021-152 - Rev 02
Valsartan, VL Process Essentially Amorphous Form
Feb 2026—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2025-145 - Rev 00
Valsartan, (1582)
Feb 2026—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
CEP 2010-065 - Rev 09
Valsartan
Jan 2026—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2025-449 - Rev 00
Valsartan, Essential Amorphous Form, Process-II
Nov 2025—
IPCA LABORATORIES LIMITED MumbaiIN
CEP 2010-100 - Rev 06
Valsartan
Sept 2025—
NINGBO MENOVO PHARMACEUTICAL CO., LTD. NingboCN
CEP 2019-258 - Rev 02
Valsartan
Aug 2025—
CPL PHARMACEUTICALS PRIVATE LIMITED AhmedabadIN
CEP 2023-282 - Rev 00
Valsartan
Apr 2025—
ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou CityCN
CEP 2020-389 - Rev 04
Valsartan, Process-II
Mar 2025—
TAPI NL B.V. AmsterdamNL
CEP 2011-121 - Rev 05
Valsartan, ID: 7611
Jan 2025—
MSN LIFE SCIENCES PRIVATE LIMITED Chandampet VillageIN
CEP 2018-275 - Rev 04
Valsartan, Micronised and non-micronised
Jan 2025Inspected Oct 2025
Slovakia
NOVARTIS PHARMA AG BaselCH
CEP 2016-290 - Rev 03
Valsartan
Oct 2024Inspected Dec 2025
Switzerland
HARMAN FINOCHEM LIMITED MumbaiIN
CEP 2016-026 - Rev 01
Valsartan
Sept 2024—
KRKA, d.d., Novo mesto Novo mestoSI
CEP 2024-137 - Rev 00
Valsartan, 319192
Aug 2024Inspected Jul 2025
Slovenia
SMILAX LABORATORIES LIMITED HyderabadIN
CEP 2023-166 - Rev 00
Valsartan
Aug 2024—
IOL CHEMICALS AND PHARMACEUTICALS LTD LudhianaIN
CEP 2023-264 - Rev 00
Valsartan
Jul 2024—
SECOND PHARMA CO., LTD. Shangyu CityCN
CEP 2014-008 - Rev 02
Valsartan
Jul 2024—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. LinhaiCN
CEP 2023-212 - Rev 01
Valsartan, Process II
May 2024Inspected May 2026
Italy
SUN PHARMACEUTICAL INDUSTRIES LIMITED MumbaiIN
CEP 2013-335 - Rev 06
Valsartan, Process 5
Jan 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2021-306 - Rev 01
Valsartan, BARIUM SALT PROCESS
Jan 2024—
ZYDUS LIFESCIENCES LIMITED VadodaraIN
R0-CEP 2020-221 - Rev 00
Valsartan
Apr 2023—
BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. HyderabadIN
R0-CEP 2021-097 - Rev 00
Valsartan
Feb 2023—
DIVI'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2012-338 - Rev 01
Valsartan
May 2020—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Valsartan are no longer active. These show a past filing, not current supply.

Show all 5 historical records

Overview

Valsartan is an angiotensin II receptor blocker (ARB) used in the management of hypertension and heart failure. It works by relaxing blood vessels so that blood can flow more easily.

Chemical identity

IUPAC name
(2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
Canonical SMILES
CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O
InChIKey
ACWBQPMHZXGDFX-QFIPXVFZSA-N
Synonyms
agsav301 component valsartan, cgp-48933, cgp48933, copalia component valsartan, copalia-hct component valsartan, dafiro component valsartan, dafiro-hct component valsartan, diovan, diovan hct component valsartan, entresto component valsartan, exforge component valsartan, exforge hct component valsartan

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Angiotensin 2 Receptor Blocker
Mechanism of action
Angiotensin 2 Receptor Antagonists

Therapeutic areas

CardiovascularHypertensionHeart Failure

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Valsartan?

35 organisations hold an active US FDA Type II Drug Master File or a CEP for Valsartan: CHANGZHOU PHARMACEUTICAL FACTORY (China), Zhejiang Tianyu Pharmaceutical Co., Ltd. (China), ZHUHAI RUNDU PHARMACEUTICAL CO LTD (China), LINHAI TIANYU PHARMACEUTICAL CO LTD (China), Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India) and Divis Laboratories (India), and 27 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Valsartan Drug Master Files are active?

CHANGZHOU PHARMACEUTICAL FACTORY (DMF 42015, 41094), Zhejiang Tianyu Pharmaceutical Co., Ltd. (DMF 33475, 32175), ZHUHAI RUNDU PHARMACEUTICAL CO LTD (DMF 32328, 25510), LINHAI TIANYU PHARMACEUTICAL CO LTD (DMF 41622, 42563), Alembic Pharmaceuticals Limited (DMF 21134, 27780), APITORIA PHARMA PRIVATE LTD (DMF 24544), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 35510) and Divis Laboratories (DMF 24797) and 20 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Valsartan records mean?

5 organisations have only inactive Type II DMFs for Valsartan. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Valsartan have a European Certificate of Suitability?

Yes. 27 organisations hold a valid CEP for Valsartan on the EDQM register, including CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram (IN), JUBILANT BIOSYS LIMITED Mysuru (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), Changzhou Pharmaceutical Factory Changzhou (CN), ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Zhuhai (CN) and HETERO LABS LIMITED Hyderabad (IN) and 21 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Valsartan supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Valsartan?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.